21.38
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Amphastar Pharmaceuticals, Inc. ($AMPH) CEO 2025 Pay Revealed - Quiver Quantitative
Amphastar (NASDAQ: AMPH) outlines 2026 virtual meeting, director and pay votes - Stock Titan
Do options traders know something about Amphastar Pharmaceuticals stock we don't? - MSN
How The Story Is Shifting For Amphastar Pharmaceuticals (AMPH) After Guidance Cut And New Launches - Yahoo Finance
AMPH Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Barclays Lowers Price Target for Amphastar Pharma (AMPH) | AMPH Stock News - GuruFocus
Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Lowered to $23.00 at Barclays - MarketBeat
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Rating of "Hold" by Brokerages - MarketBeat
Understanding Momentum Shifts in (AMPH) - Stock Traders Daily
Amphastar Pharmaceuticals to Present at the 25th Annual Needham Healthcare Conference - ACCESS Newswire
Amphastar CFO, regulatory chief to present April 14; replay lasts 30 days - Stock Titan
Amphastar Pharmaceuticals, Inc. (AMPH) stock price, news, quote and history - Yahoo Finance Australia
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Price, News, Quote & History - Yahoo! Finance Canada
AMPH Earning Date, Earning Analysis and Earning Prediction - intellectia.ai
SG Americas Securities LLC Makes New Investment in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharma (AMPH) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Forecasts - Yahoo! Finance Canada
Amphastar Pharmaceuticals, Inc. (AMPH) Stock forecasts - Yahoo Finance UK
Amphastar Pharmaceuticals (NASDAQ:AMPH) Share Price Passes Below Two Hundred Day Moving AverageShould You Sell? - MarketBeat
Vanguard reports 0 shares of Amphastar (amendment) | AMPH SEC FilingForm SCHEDULE 13G/A - Stock Titan
Volume Recap: Is Amphastar Pharmaceuticals Inc forming a double bottom2026 Volatility Report & High Accuracy Swing Trade Signals - baoquankhu1.vn
Portfolio Update: Is Amphastar Pharmaceuticals Inc backed by strong institutional buyingPortfolio Risk Summary & Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Aug Outlook: Can Amphastar Pharmaceuticals Inc stock outperform in a bear marketWeekly Investment Recap & AI Driven Price Forecasts - baoquankhu1.vn
Stock Market Recap: Is Amphastar Pharmaceuticals Inc a potential multi bagger2026 Volatility Report & Fast Gaining Stock Reports - baoquankhu1.vn
Amphastar (AMPH) EVP Yakob has 1,033 shares withheld for RSU tax - Stock Titan
[Form 4] Amphastar Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Tax withholding trims Amphastar (NASDAQ: AMPH) exec's RSU shares - Stock Titan
Tax withholding on RSU vesting for Amphastar (AMPH) CFO Peters - Stock Titan
Discipline and Rules-Based Execution in AMPH Response - Stock Traders Daily
NeoGenomics, Natera, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know - Yahoo Finance
NeoGenomics, Natera, and Amphastar Pharmaceuticals shares skyrocket, what you need to know - MSN
Amphastar Pharmaceuticals Inc authorizes $50 million increase to share buyback program on March 12, 2026SEC filing - marketscreener.com
Amphastar Pharmaceuticals IncAuthorizes $50 Million Increase To Share Buyback Program On March 12, 2026SEC Filing - TradingView
Amphastar Expands Share Repurchase Authorization to Manage Equity - TipRanks
Amphastar Pharmaceuticals boosts buyback program by $50 million - TradingView
Amphastar (NASDAQ: AMPH) adds $50 million to share buyback program - Stock Titan
Clark Capital Management Group Inc. Invests $7.56 Million in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Algert Global LLC Acquires 268,612 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals: Why I Like Bull Put Options Strategy Here (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Receives Average Rating of "Hold" from Analysts - MarketBeat
Amphastar reports FDA approval for teriparatide injection - MSN
Amphastar Pharmaceuticals, Inc. (AMPH) Presents at Barclays 28th Annual Global Healthcare ConferenceSlideshow - Seeking Alpha
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowShould You Sell? - MarketBeat
Amphastar (AMPH) CFO granted RSUs, stock options and withholds shares for taxes - Stock Titan
Risk Report: Can Amphastar Pharmaceuticals Inc maintain its current growth rateRate Hike & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Amphastar (AMPH) exec granted RSUs, options and reports tax share withholding - Stock Titan
Amphastar (NASDAQ: AMPH) EVP receives RSUs and stock option grant - Stock Titan
Equity awards and tax withholding for Amphastar Pharmaceuticals (AMPH) insiders - Stock Titan
Amphastar (AMPH) CFO Peters reports 2,146-share tax-withholding on RSU vesting - Stock Titan
Amphastar (AMPH) CEO logs 10,850-share RSU tax withholding, retains large stake - Stock Titan
Amphastar Pharmaceuticals : Barclays 28th Annual Global Healthcare Conference Presentation - marketscreener.com
Amphastar (AMPH) senior EVP uses 1,357 shares to cover RSU taxes, retains over 240K - Stock Titan
AMPH SEC FilingsAmphastar Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Quantbot Technologies Cuts Stake in Amphastar Pharmaceuticals - nationaltoday.com
Aug Shorts: Can Amphastar Pharmaceuticals Inc maintain its current growth rateJuly 2025 Price Swings & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Can Amphastar Pharmaceuticals Inc. stock reach $100 price targetIPO Watch & Daily Profit Maximizing Trade Tips - Naître et grandir
Risk Check: Is Amphastar Pharmaceuticals Inc a potential multi baggerGold Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):